Search hospitals > South Carolina > Greenville
Prisma Health Cancer Institute - Butternut
Claim this profileGreenville, South Carolina 29605
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
258 reported clinical trials
6 medical researchers
Summary
Prisma Health Cancer Institute - Butternut is a medical facility located in Greenville, South Carolina. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Cancer, Breast cancer and other specialties. Prisma Health Cancer Institute - Butternut is involved with conducting 258 clinical trials across 458 conditions. There are 6 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Suzanne R. Fanning.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Ki Chung, MDPrisma Health Cancer Institute - Eastside6 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Cystic Tumor
97 reported clinical trials
199 drugs studied
Aniket SahaBI-LO Charities Children's Cancer Center8 years of reported clinical research
Expert in Cancer
Expert in Gliomas
59 reported clinical trials
120 drugs studied
Jeffrey K. GiguerePrisma Health Cancer Institute - Faris8 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
26 reported clinical trials
64 drugs studied
Suzanne R. FanningPrisma Health Cancer Institute - Eastside2 years of reported clinical research
Studies Adult T-Cell Leukemia/Lymphoma
Studies Lymphoma
12 reported clinical trials
35 drugs studied
Clinical Trials running at Prisma Health Cancer Institute - Butternut
Breast Cancer
Breast cancer
Cancer
Parotid Gland Cancer
Lung Cancer
Cystic Tumor
Bladder Cancer
Kidney Cancer
Testicular cancer
Acute Myeloid Leukemia
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Prisma Health Cancer Institute - Butternut?
Prisma Health Cancer Institute - Butternut is a medical facility located in Greenville, South Carolina. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Cancer, Breast cancer and other specialties. Prisma Health Cancer Institute - Butternut is involved with conducting 258 clinical trials across 458 conditions. There are 6 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Suzanne R. Fanning.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.